GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Smruthi Organics Ltd (BOM:540686) » Definitions » Cash Flow for Lease Financing

Smruthi Organics (BOM:540686) Cash Flow for Lease Financing : ₹0 Mil (TTM As of Mar. 2024)


View and export this data going back to 2005. Start your Free Trial

What is Smruthi Organics Cash Flow for Lease Financing?

Smruthi Organics's Cash Flow for Lease Financing for the three months ended in Mar. 2024 was ₹0 Mil. Smruthi Organics's Cash Flow for Lease Financing for the trailing twelve months (TTM) ended in Mar. 2024 was ₹0 Mil.

Compared with last quarter (₹0 Mil in Dec. 2023 ), Smruthi Organics's Cash Flow for Lease Financing remained the same in Mar. 2024 (₹0 Mil).

Smruthi Organics Cash Flow for Lease Financing Historical Data

The historical data trend for Smruthi Organics's Cash Flow for Lease Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Smruthi Organics Cash Flow for Lease Financing Chart

Smruthi Organics Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Cash Flow for Lease Financing
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -0.35

Smruthi Organics Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cash Flow for Lease Financing Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Smruthi Organics Cash Flow for Lease Financing Calculation

Cash Flow for Lease Financing is change in cash flow resulting from increase or decrease in lease financing.


Cash Flow for Lease Financing for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Smruthi Organics Cash Flow for Lease Financing Related Terms

Thank you for viewing the detailed overview of Smruthi Organics's Cash Flow for Lease Financing provided by GuruFocus.com. Please click on the following links to see related term pages.

Smruthi Organics (BOM:540686) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Smruthi Organics Ltd (BOM:540686) » Definitions » Cash Flow for Lease Financing
Comparable Companies
BOM:531739 BOM:532989 BOM:531726 BOM:530313 BOM:530163 BOM:532384 BOM:532637 BOM:531173 BOM:532878 BOM:524518 ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692
Traded in Other Exchanges
N/A
Address
165-A, Balaji Bhavan, 1st Floor, Railway Lines, Solapur, MH, IND, 413 001
Website
https://www.smruthiorganics.com
Smruthi Organics Ltd is engaged in the manufacture of bulk drugs and drug intermediates (API Products). The product portfolio includes Amlodipine Besilate, Amlodipine Base, S-Amlodipine Besilate, S-Amlodipine Base, Norfloxacin, Metformin HCI, Diloxanide Furoate, Phthaloyl Amlodipine, Pantoprazole Sodium, Pefloxacin Mesylate Dihydrate, Telmisartan, Losartan Potassium and many more. It has two segments Bulk Drugs and Drugs Intermediates (API) and Formulation. it generates the majority of its revenue from the Bulk Drugs and Drugs Intermediates (API) segment.

Smruthi Organics (BOM:540686) Headlines

No Headlines